North America Medical Injection Molding Market Size and Forecast (2021 - 2031)

The North America Medical Injection Molding Market is projected to grow from US$ 2,016.8 Million in 2024 to US$ 2,745.5 Million by 2031, reflecting a compound annual growth rate (CAGR) of 4.5% during this period.

Executive Summary and Market Analysis

The medical injection molding market in North America is divided into three main regions: the United States, Canada, and Mexico. Key drivers of market growth include the region's strong healthcare infrastructure and the rising demand for high-quality medical devices such as syringes, catheters, and diagnostic tools. Additionally, advancements in medical technology and the increasing prevalence of chronic diseases necessitate precise and cost-effective manufacturing processes like injection molding. The trend towards minimally invasive surgeries and personalized medicine further enhances the demand for innovative, high-performance medical products in North America.

Strategic Insights

Market Segmentation Analysis

• By Material: The market is segmented into Polyvinyl Chloride (PVC), Poly(methyl methacrylate) (PMMA), Polyether Ether Ketone (PEEK), Metals, and Others, with Others holding the largest market share in 2024.
• By Type: Segmentation includes Plastic Injection Molding, Overmolding, Liquid Silicone Molding, and Others, where Plastic Injection Molding leads the market.
• By End User: The market is divided into Medical Devices Companies, Pharmaceutical Drug Packaging Companies, Surgical Instruments Companies, and Others, with Medical Devices Companies dominating.
• By Product Type: This includes Medical Equipment Components, Consumables, Patient Aids, Orthopedic Instruments, Dental Products, and Others, with Medical Equipment Components having the largest share.
• By System: The market is categorized into Hot Runner and Cold Runner systems, with Hot Runner leading in 2024.

Market Outlook

Innovations such as all-electric injection molding and micro-molding are significantly impacting the production of medical devices, driving the growth of the medical injection molding market. All-electric machines are particularly valued for their energy efficiency and precise control, essential for producing high-quality medical components. These machines are compatible with cleanroom environments, ensuring contamination-free production that meets stringent hygiene standards. Micro-molding technology enables the creation of extremely small and precise parts, crucial for modern medical devices like implants and diagnostic tools. Together, these advancements enhance manufacturing processes, reduce waste, and uphold the high standards required in medical device production.

Key companies like MTD Micro Moulding, Makuta Technics Inc., Accumold, Sungplastic, and WestFall Technik are leading the way in injection molding technologies, particularly in all-electric machines and micro-molding, to improve precision, efficiency, and cleanliness in medical device manufacturing. For instance, MTD Micro Moulding expanded its micro injection molding facility in 2021 to meet the growing demand for ultra-precision molded components. Tederic Machinery Co. launched the NEO series of electric, hybrid injection molding machines in April 2021, which offer significant energy savings. ENGEL introduced e-speed injection molding machines in September 2020, aimed at producing thin-walled containers and other products.

Government support through subsidies for healthcare equipment and funding for medical device research has also contributed to market growth. The US government has historically invested heavily in healthcare infrastructure, fostering innovation and increasing demand for advanced medical devices. For example, DuPont's acquisition of Spectrum Plastics Group in August 2023 for USD 1.75 billion enhances its medical device portfolio and injection molding capabilities.

The rise of micro-molding technologies allows for the production of highly precise miniature parts, essential for modern medical devices. There is also a growing trend towards bio-based materials to meet the demand for environmentally sustainable medical products. Companies like Accumold, MTD Micro Moulding, and Makuta Technics are focusing on enhancing their micro-molding capabilities, while DuPont and Cavestro are leading advancements in bio-based materials.

Country Insights

The North America Medical Injection Molding Market is primarily segmented into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. The growth in the US market is driven by the increasing demand for medical devices and components necessary for diagnosing, treating, and monitoring health conditions. The aging population and the rising incidence of chronic diseases, such as diabetes and cardiovascular diseases, are significant factors driving this demand. According to the CDC, approximately 60% of American adults suffer from at least one chronic disease, leading to a higher need for medical devices.

Milacron, LLC is a key player in the US market, offering a range of injection molding machines and related equipment. The increasing adoption of single-use medical devices for infection control has further boosted the demand for injection-molded components.

Company Profiles

Key players in the North America Medical Injection Molding Market include Biomerics LLC, Ensinger, Aberdeen Technologies, Inc., Husky Technologies, The Rodon Group, Kaysun Corporation, UPG International, C&J Industries, Sanner GmbH, Feronyl, HTI Plastics, Tessy Plastics, and Proto Labs. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products. Show more